JAVIER
PUENTE VÁZQUEZ
Profesor asociado
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (6)
2022
-
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer, Vol. 175, pp. 110-119
2020
-
Latest progress in molecular biology and treatment in genitourinary tumours
Clinical and Translational Oncology, Vol. 22, Núm. 12, pp. 2175-2195
2019
-
Real-world outcome of 173 metastatic non-clear cell renal cell carcinoma (nccrcc) cases: The experience of the center group for genitourinary tumors
Kidney Cancer, Vol. 3, Núm. 1, pp. 41-50
-
Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study
Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 781-789
2016
-
Retrospective analysis of metastatic non-clear cell renal carcinoma (NCCRC): the Spanish Grupo Centro Experience
Annals of Oncology, Vol. 27, pp. vi290